FDCA Carried Out “Absolutely Perfunctory, Premeditated And Peripheral Inquiry”: Dhanani To HC

Ahmedabad : Leader of Opposition in Gujarat Assembly, Paresh Dhanani, has termed the preliminary inquiry by the Food and Drug Control Administration (FDCA) that gave a clean chit to BJP state chief CR Paatil who distributed Covid drug from BJP office in Surat as “politically motivated and completely biased”.

In a rejoinder affidavit filed before the Gujarat High Court in connection with his petition on the “illegal distribution” of Remdesivir, Dhanani has relied on the Delhi High Court order that expressed dissatisfaction with the Drug Controller’s investigation and clean chit to BJP MP Gautam Gambhir and AAP MLAs of Delhi, who had distributed Fabiflu in Delhi during the peak of second wave of the Covid pandemic.

Navsari MP and Gujarat BJP president CR Paatil and MLA Harsh Sanghvi courted controversy in April when amid a dire shortage of the antiviral drug Remdesivir, Paatil had announced that 5,000 vials of the drug would be given free of cost to needy patients from Surat BJP office.

Contesting the clean chit given by Food and Drug Control Administration (FDCA) to Paatil and Sanghavi based on preliminary inquiry, a report of which was filed before the HC, Dhanani submitted that the FDCA has carried out “absolutely perfunctory, premeditated and peripheral inquiry inconsistent with the statutory obligation and devoid of their statutory functions and duties”.

Dhanani highlighted that his PIL raises two fundamental questions — one about two elected representatives belonging to BJP taking lead in purchasing, collecting, hoarding and distributing Remdesivir on charity from the BJP office with a political overtone and the second “abject failure on the part of Respondent 7 (FDCA)” in implementing Central government’s directives and failing to ensure that “no private individuals or association collects Remdesivir injection in large number and distributes the same in private initiative”. The matter has been posted for further hearing for August 4.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs